Vanguard Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.65B Buy
14,261,860
+106,030
+0.7% +$27.8M 0.05% 323
2025
Q3
$3.68B Sell
14,155,830
-43,266
-0.3% -$11.4M 0.06% 321
2025
Q2
$3.47B Buy
14,199,096
+226,224
+2% +$56.4M 0.06% 325
2025
Q1
$3.7B Buy
13,972,872
+1,143,662
+9% +$309M 0.07% 289
2024
Q4
$3.25B Buy
12,829,210
+1,751,857
+16% +$470M 0.06% 329
2024
Q3
$3.51B Buy
11,077,353
+81,414
+0.7% +$29M 0.06% 308
2024
Q2
$4.11B Sell
10,995,939
-80,291
-0.7% -$27.1M 0.08% 246
2024
Q1
$3.84B Sell
11,076,230
-94,879
-0.8% -$36M 0.08% 266
2023
Q4
$5.11B Sell
11,171,109
-14,074
-0.1% -$6.94M 0.11% 160
2023
Q3
$5.44B Sell
11,185,183
-70,552
-0.6% -$33.2M 0.13% 133
2023
Q2
$5.03B Sell
11,255,735
-6,412
-0.1% -$3.23M 0.12% 150
2023
Q1
$5.47B Sell
11,262,147
-95,827
-0.8% -$47.4M 0.14% 131
2022
Q4
$5.82B Buy
11,357,974
+176,661
+2% +$92.9M 0.16% 114
2022
Q3
$5.43B Buy
11,181,313
+147,619
+1% +$71.8M 0.16% 112
2022
Q2
$5.16B Buy
11,033,694
+106,047
+1% +$47.2M 0.15% 123
2022
Q1
$4.76B Buy
10,927,647
+919,325
+9% +$385M 0.11% 171
2021
Q4
$4.64B Sell
10,008,322
-17,825
-0.2% -$7.89M 0.11% 179
2021
Q3
$3.9B Sell
10,026,147
-21,149
-0.2% -$8.98M 0.1% 194
2021
Q2
$4.45B Buy
10,047,296
+38,633
+0.4% +$16.9M 0.11% 159
2021
Q1
$4.2B Sell
10,008,663
-160,222
-2% -$64M 0.11% 152
2020
Q4
$4.17B Sell
10,168,885
-66,196
-0.6% -$27.5M 0.12% 143
2020
Q3
$4.24B Sell
10,235,081
-137,339
-1% -$55.2M 0.14% 125
2020
Q2
$4.02B Sell
10,372,420
-133,285
-1% -$49.9M 0.14% 127
2020
Q1
$3.3B Buy
10,505,705
+313,147
+3% +$106M 0.14% 134
2019
Q4
$3.74B Sell
10,192,558
-109,872
-1% -$34.8M 0.13% 150
2019
Q3
$2.63B Buy
10,302,430
+75,916
+0.7% +$21.3M 0.1% 213
2019
Q2
$2.71B Sell
10,226,514
-165,332
-2% -$41.9M 0.1% 199
2019
Q1
$2.76B Buy
10,391,846
+46,682
+0.5% +$13.5M 0.11% 181
2018
Q4
$2.96B Buy
10,345,164
+240,939
+2% +$76.4M 0.13% 146
2018
Q3
$3.42B Buy
10,104,225
+140,864
+1% +$45.8M 0.13% 134
2018
Q2
$2.97B Buy
9,963,361
+149,355
+2% +$43.7M 0.12% 159
2018
Q1
$2.64B Sell
9,814,006
-24,743
-0.3% -$6.7M 0.12% 178
2017
Q4
$2.44B Sell
9,838,749
-199,556
-2% -$49.3M 0.11% 185
2017
Q3
$2.45B Buy
10,038,305
+145,670
+1% +$35.7M 0.11% 175
2017
Q2
$2.38B Buy
9,892,635
+157,868
+2% +$35.7M 0.12% 171
2017
Q1
$2.01B Buy
9,734,767
+339,620
+4% +$70.2M 0.1% 194
2016
Q4
$1.92B Buy
9,395,147
+203,332
+2% +$38.8M 0.11% 184
2016
Q3
$1.63B Buy
9,191,815
+227,323
+3% +$39.4M 0.1% 222
2016
Q2
$1.61B Buy
8,964,492
+219,311
+3% +$39M 0.1% 214
2016
Q1
$1.6B Buy
8,745,181
+284,250
+3% +$49.3M 0.1% 200
2015
Q4
$1.51B Buy
8,460,931
+181,672
+2% +$31.9M 0.1% 198
2015
Q3
$1.48B Buy
8,279,259
+39,472
+0.5% +$7.3M 0.11% 188
2015
Q2
$1.58B Buy
8,239,787
+107,775
+1% +$20M 0.11% 189
2015
Q1
$1.45B Buy
8,132,012
+130,543
+2% +$20.7M 0.1% 217
2014
Q4
$1.15B Buy
8,001,469
+209,646
+3% +$28.6M 0.08% 260
2014
Q3
$1.02B Buy
7,791,823
+166,962
+2% +$21.2M 0.08% 267
2014
Q2
$974M Buy
7,624,861
+158,561
+2% +$18.8M 0.08% 282
2014
Q1
$842M Buy
7,466,300
+125,417
+2% +$13.1M 0.07% 303
2013
Q4
$758M Buy
7,340,883
+74,312
+1% +$7.28M 0.07% 323
2013
Q3
$678M Buy
7,266,571
+105,754
+1% +$9.7M 0.07% 325
2013
Q2
$604M Buy
+7,160,817
New +$565M 0.06% 345

Other funds holding HUM

Vanguard Group's HUM Position: Q4 2025 in Review

Vanguard Group increased its Humana (HUM) stake by 0.75% in Q4 2025, buying an estimated $27.8M and bringing the position to 14,261,860 shares worth $3.65B. The position accounts for 0.05% of the portfolio, ranked #323.

Vanguard Group first reported a position in HUM in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.82B in Q4 2022. 863 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Vanguard Group held 14,261,860 shares of Humana worth $3.65B as of Q4 2025.
  • Vanguard Group bought 106,030 Humana shares in Q4 2025, an estimated $27.8M.
  • Humana made up 0.05% of Vanguard Group's portfolio in Q4 2025, its #323 holding.
  • Vanguard Group first reported a position in Humana in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Humana position peaked at $5.82B in Q4 2022.
  • 863 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.